{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:46:37Z","timestamp":1792039597015,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lungcan.2026.109584","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:39:42Z","timestamp":1786721982000},"page":"109584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-small cell lung cancer with synchronous oligometastatic disease at the time of initial diagnosis. Impact of multimodal treatment on prognosis"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-4517","authenticated-orcid":false,"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-4309","authenticated-orcid":false,"given":"Seyer","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Tufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7369-4512","authenticated-orcid":false,"given":"Niels","family":"Reinmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Hackanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3928-3331","authenticated-orcid":false,"given":"Florian","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hildner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Heudobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109584_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2026.109584_b0010","first-page":"1824","article-title":"Update of Incidence, Prevalence, Survival, and initial Treatment in patients with Non-Small Cell Lung Cancer in the US, JAMA","volume":"7","author":"Ganti","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.lungcan.2026.109584_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0020","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-a Consensus Report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0025","doi-asserted-by":"crossref","unstructured":"F.C. Detterbeck, D.J. Boffa, A.W. Kim, L.T. Tanoue, The Eighth Edition Lung Cancer Stage Classification, Chest 151 (2017) 193\u2013203. https:\/\/doi.org\/10.1016\/j.chest.2016.10.010.","DOI":"10.1016\/j.chest.2016.10.010"},{"key":"10.1016\/j.lungcan.2026.109584_b0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12032-018-1182-8","article-title":"Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer","volume":"35","author":"Gibson","year":"2018","journal-title":"Med. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clon.2022.03.010","article-title":"Gender differences and their Effects on Survival Outcomes in Lung Cancer patients Treated with PD-1\/PD-L1 Checkpoint Inhibitors","volume":"34","author":"Madala","year":"2022","journal-title":"A Systematic Review and Meta-Analysis, Clin. Oncol. (r Coll. Radiol)"},{"key":"10.1016\/j.lungcan.2026.109584_b0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JTO.0000000000000416","article-title":"Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer","volume":"10","author":"Mellemgaard","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01336-2022","article-title":"Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry","volume":"61","author":"Metzenmacher","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2026.109584_b0050","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/cncr.24333","article-title":"Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases","volume":"115","author":"Oh","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2026.109584_b0055","first-page":"3339","article-title":"Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis, Transl. Lung","volume":"10","author":"Gobbini","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109584_b0060","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local Consolidative Therapy Vs. Maintenance Therapy or Observation for patients with Oligometastatic Non-Small-Cell Lung Cancer: Long-Term results of a Multi-institutional, phase II, Randomized Study","volume":"37","author":"Gomez","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0065","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jtho.2017.05.015","article-title":"Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases","volume":"12","author":"Lodeweges","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cas.14707","article-title":"Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy","volume":"112","author":"Miyawaki","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2026.109584_b0075","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2026.109584_b0080","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","article-title":"Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450)","volume":"7","author":"de Ruysscher","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101892","article-title":"Evolution of treatment strategies for oligometastatic NSCLC patients - a systematic review of the literature","volume":"80","author":"Schanne","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2026.109584_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11912-012-0240-1","article-title":"Management of non-small cell lung cancer with oligometastasis","volume":"14","author":"Villaruz","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.lungcan.2026.109584_b0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2026.109584_b0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.lungcan.2018.09.021","article-title":"Local ablative treatment for synchronous single organ oligometastatic lung cancer-a propensity score analysis of 180 patients","volume":"125","author":"Frost","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109584_b0105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized Trial of First-Line Tyrosine Kinase Inhibitor with or without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.lungcan.2026.109584_b0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.athoracsur.2017.10.040","article-title":"Operation and chemotherapy: prognostic factors for lung cancer with one synchronous metastasis","volume":"105","author":"Toffart","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2026.109584_b0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.lungcan.2021.11.009","article-title":"Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery","volume":"164","author":"Boch","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109584_b0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13014-020-01651-y","article-title":"The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease","volume":"15","author":"Zeng","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0125","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231183668","article-title":"Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions","volume":"15","author":"Zayed","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.lungcan.2026.109584_b0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ijc.35199","article-title":"Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome","volume":"156","author":"Wiesweg","year":"2025","journal-title":"Int. J. Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:08:03Z","timestamp":1792037283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S0169500226006458"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109584","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-small cell lung cancer with synchronous oligometastatic disease at the time of initial diagnosis. Impact of multimodal treatment on prognosis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109584"}}